Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma

Condition:   Relapsed or Refractory Synovial Sarcoma Interventions:   Drug: OTSA101-DTPA-111In;   Drug: OTSA101-DTPA-90Y Sponsor:   OncoTherapy Science, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials